Alpha imaging confirmed efficient targeting of CD45-positive cells after astatine-211 ((211)At)-radioimmunotherapy for hematopoietic cell transplantation

類似資料

• Biodistributions, Myelosuppression and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211
  著者:: Nakamae, Hirohisa, 等
  出版事項: (2009)
• Reagents for Astatination of Biomolecules. 4. Comparison of Maleimido-closo-Decaborate(2-) and meta-[(211)At]Astatobenzoate Conjugates for Labeling anti-CD45 Antibodies with [(211)At]Astatine
  著者:: Wilbur, D. Scott, 等
  出版事項: (2009)
• Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211–labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation
  著者:: Chen, Yun, 等
  出版事項: (2012)
• Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model
  著者:: Orozco, Johnnie J., 等
  出版事項: (2013)
• Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model
  著者:: Green, Damian J., 等
  出版事項: (2015)